- Author:
Hyo Sun SHIN
1
;
Sang Hyun KIM
;
Hack Lyoung KIM
;
Jae Bin SEO
;
Woo Young CHUNG
;
Joo Hee ZO
;
Myung A KIM
Author Information
- Publication Type:Case Report
- Keywords: Coronary thrombosis; Acute coronary syndrome; Abciximab
- MeSH: Acute Coronary Syndrome*; Angioplasty, Balloon; Chest Pain; Coronary Thrombosis; Glycoproteins; Humans; Incidence; Infusions, Intravenous; Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Risk Factors; Stents*; Thrombosis*
- From:Journal of Lipid and Atherosclerosis 2014;3(1):43-48
- CountryRepublic of Korea
- Language:English
- Abstract: Acute stent thrombosis after percutaneous coronary intervention (PCI) is still problematic because of the subsequent development of myocardial infarction and poor prognosis. The incidence of acute stent thrombosis, occurring within 0-24hours after PCI, is relatively low, but underlying causes and treatment strategy are not well defined. Multi-vessel disease, ST-elevated myocardial infarction (STEMI), and large thrombotic burden are known risk factors of acute stent thrombosis. Thrombus aspiration, balloon angioplasty and glycoprotein IIb/IIIa receptor blocker could be therapeutic options. Recently we experienced two cases of acute stent thrombosis which developed during PCI with the aggravation of chest pain, and acute stent thrombosis were diagnosed immediately and successfully treated. Here we report two cases of acute stent thrombosis during PCI for one patient with STEMI and the other with acute coronary syndrome, which were successfully treated with thrombus aspiration and intravenous infusion of glycoprotein IIb/IIIa receptor blocker.